All News Department News

Startup company founded by WU scientists acquired by Eli Lilly

Dr. Aaron DiAntonio headshot
View Content

“Pharmaceutical maker Eli Lilly and Company has purchased Disarm Therapeutics, a startup biotechnology firm founded by researchers at Washington University School of Medicine in St. Louis. Disarm Therapeutics was co-founded by Jeffrey Milbrandt, MD, PhD, and Aaron DiAntonio, MD, PhD, to speed the development of treatments for multiple neurodegenerative conditions.”

Congratulations to Dr. Aaron DiAntonio!

To read more, click here